CN111518225A - 羊种布鲁氏菌疫苗株m5提取的脂多糖在制备诊断人布鲁氏菌病的产品中的应用 - Google Patents
羊种布鲁氏菌疫苗株m5提取的脂多糖在制备诊断人布鲁氏菌病的产品中的应用 Download PDFInfo
- Publication number
- CN111518225A CN111518225A CN202010342566.8A CN202010342566A CN111518225A CN 111518225 A CN111518225 A CN 111518225A CN 202010342566 A CN202010342566 A CN 202010342566A CN 111518225 A CN111518225 A CN 111518225A
- Authority
- CN
- China
- Prior art keywords
- gold
- antibody
- lipopolysaccharide
- labeled
- pad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002158 endotoxin Substances 0.000 title claims abstract description 102
- 229920006008 lipopolysaccharide Polymers 0.000 title claims abstract description 100
- 241001148106 Brucella melitensis Species 0.000 title claims abstract description 51
- 229940038698 brucella melitensis Drugs 0.000 title claims abstract description 51
- 229960005486 vaccine Drugs 0.000 title claims abstract description 34
- 206010006500 Brucellosis Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 104
- 238000001514 detection method Methods 0.000 claims abstract description 49
- 108091007433 antigens Proteins 0.000 claims abstract description 42
- 102000036639 antigens Human genes 0.000 claims abstract description 42
- 239000000427 antigen Substances 0.000 claims abstract description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 20
- 201000010099 disease Diseases 0.000 claims abstract description 19
- 238000012360 testing method Methods 0.000 claims description 51
- 238000011282 treatment Methods 0.000 claims description 44
- 241001494479 Pecora Species 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 25
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 244000052616 bacterial pathogen Species 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 18
- 238000003908 quality control method Methods 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 13
- 241000283707 Capra Species 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 239000000020 Nitrocellulose Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229920001220 nitrocellulos Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 241000282412 Homo Species 0.000 claims 1
- 241000589562 Brucella Species 0.000 abstract description 22
- 208000015181 infectious disease Diseases 0.000 abstract description 15
- 238000003745 diagnosis Methods 0.000 abstract description 14
- 230000002458 infectious effect Effects 0.000 abstract description 6
- 230000009257 reactivity Effects 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 46
- 238000010171 animal model Methods 0.000 description 22
- 210000002966 serum Anatomy 0.000 description 20
- 239000010931 gold Substances 0.000 description 14
- 229910052737 gold Inorganic materials 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 14
- 241000191967 Staphylococcus aureus Species 0.000 description 12
- 241000607762 Shigella flexneri Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 238000009835 boiling Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 8
- 108010013639 Peptidoglycan Proteins 0.000 description 8
- 238000007789 sealing Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 241001517299 Bulbophyllum Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241001052560 Thallis Species 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000012880 LB liquid culture medium Substances 0.000 description 4
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 102000018697 Membrane Proteins Human genes 0.000 description 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 241000222455 Boletus Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241001148111 Brucella suis Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- 241000589568 Brucella ovis Species 0.000 description 2
- 241000202726 Bupleurum Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 206010014096 Echinococciasis Diseases 0.000 description 1
- 208000009366 Echinococcosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000729876 Niveus Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 241000209501 Spirodela Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000007382 columbia agar Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004833 fish glue Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/23—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Brucella (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Sustainable Development (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
样品来源 | RBPT阳性数(例) | SAT阳性数(例) | 金标阳性数(例) | 敏感度% |
霍城县 | 35 | 35 | 35 | 100 |
裕民县 | 39 | 39 | 39 | 100 |
托里县 | 40 | 40 | 40 | 100 |
额敏县 | 25 | 25 | 25 | 100 |
合计 | 139 | 139 | 139 | 100 |
样品来源 | ELISA阳性数(例) | 金标阳性数(例) | 敏感度%(例) |
新疆塔城地区 | 19 | 19 | 100 |
合计 | 19 | 19 | 100 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010342566.8A CN111518225B (zh) | 2020-04-27 | 2020-04-27 | 羊种布鲁氏菌疫苗株m5提取的脂多糖在制备诊断人布鲁氏菌病的产品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010342566.8A CN111518225B (zh) | 2020-04-27 | 2020-04-27 | 羊种布鲁氏菌疫苗株m5提取的脂多糖在制备诊断人布鲁氏菌病的产品中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111518225A true CN111518225A (zh) | 2020-08-11 |
CN111518225B CN111518225B (zh) | 2021-08-17 |
Family
ID=71906305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010342566.8A Expired - Fee Related CN111518225B (zh) | 2020-04-27 | 2020-04-27 | 羊种布鲁氏菌疫苗株m5提取的脂多糖在制备诊断人布鲁氏菌病的产品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111518225B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115166239A (zh) * | 2022-08-02 | 2022-10-11 | 中国农业科学院北京畜牧兽医研究所 | 牛布鲁氏菌病初筛和确诊一体化抗体检测试纸条 |
CN115166238A (zh) * | 2022-08-02 | 2022-10-11 | 中国农业科学院北京畜牧兽医研究所 | 羊布鲁氏菌病初筛和确诊一体化抗体检测试纸条 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103864928A (zh) * | 2012-12-13 | 2014-06-18 | 中国农业科学院哈尔滨兽医研究所 | 布鲁氏菌脂多糖共同抗原单克隆抗体的制备及c-ELISA方法的建立 |
CN105158463A (zh) * | 2015-08-06 | 2015-12-16 | 中国兽医药品监察所 | 羊布鲁氏菌胶体金抗体检测试纸条 |
CN109813885A (zh) * | 2019-03-25 | 2019-05-28 | 中国动物卫生与流行病学中心 | 一种牛布鲁氏菌病和牛结核病二联试纸条检测卡 |
-
2020
- 2020-04-27 CN CN202010342566.8A patent/CN111518225B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103864928A (zh) * | 2012-12-13 | 2014-06-18 | 中国农业科学院哈尔滨兽医研究所 | 布鲁氏菌脂多糖共同抗原单克隆抗体的制备及c-ELISA方法的建立 |
CN105158463A (zh) * | 2015-08-06 | 2015-12-16 | 中国兽医药品监察所 | 羊布鲁氏菌胶体金抗体检测试纸条 |
CN109813885A (zh) * | 2019-03-25 | 2019-05-28 | 中国动物卫生与流行病学中心 | 一种牛布鲁氏菌病和牛结核病二联试纸条检测卡 |
Non-Patent Citations (4)
Title |
---|
GANTSETSEG TUMURKHUU等: "Characterization of Biological Activities of Brucella melitensis Lipopolysaccharide", 《MICROBIOL. IMMUNOL.》 * |
ISMAIL KOYUNCU等: "Diagnostic potential of Brucella melitensis Rev1 native Omp28 precursor in human brucellosis", 《CLINICAL IMMUNOLOGY》 * |
德育慧等: "布鲁菌脂多糖的制备及其免疫效果的初步评价", 《动物医学进展》 * |
王艳等: "稳定分泌坑勒晰胡戮绷鸽糖单克隆园瞬瞬蛛的筛选与应用", 《第十二次人兽共患病学术研讨会暨第六届第十四次教学专业委员会论文集》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115166239A (zh) * | 2022-08-02 | 2022-10-11 | 中国农业科学院北京畜牧兽医研究所 | 牛布鲁氏菌病初筛和确诊一体化抗体检测试纸条 |
CN115166238A (zh) * | 2022-08-02 | 2022-10-11 | 中国农业科学院北京畜牧兽医研究所 | 羊布鲁氏菌病初筛和确诊一体化抗体检测试纸条 |
Also Published As
Publication number | Publication date |
---|---|
CN111518225B (zh) | 2021-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Berdal et al. | Detection of Legionella pneumonophila antigen in urine by enzyme-linked immunospecific assay | |
JP4634148B2 (ja) | 試料中の微生物を検出して、計数するための方法 | |
CN111518225B (zh) | 羊种布鲁氏菌疫苗株m5提取的脂多糖在制备诊断人布鲁氏菌病的产品中的应用 | |
CN101923091B (zh) | 用于检测高敏感性的结核分枝杆菌的试剂盒 | |
JP2004529350A (ja) | カンジダの検出 | |
CN109182167B (zh) | 一种高效价结核菌素皮试诊断试剂(ppd)生产工艺 | |
CN106556701A (zh) | 羊布鲁氏菌间接elisa抗体检测试剂盒 | |
CN113092755A (zh) | 一种夹心法检测布鲁氏菌抗原的胶体金检测试纸条 | |
RU2642588C1 (ru) | Иммунохроматографическая тест-система для выявления патогенных штаммов helicobacter pylori | |
JP4268358B2 (ja) | 抗体および免疫学的測定方法 | |
KR100877913B1 (ko) | 돼지혈청으로부터 일본뇌염바이러스 항체 검출을 위한면역크로마토그래피 진단 키트 | |
JPS58183627A (ja) | 免疫生物学的調製物 | |
Seleim et al. | ELISA and other tests in the diagnosis of Pasteurella multocida infection in camels | |
JPS60259966A (ja) | 細菌および菌類感染の迅速検出方法 | |
CN113322268A (zh) | 一种非洲猪瘟病毒p72重组蛋白及其构建的胶体金免疫层析试纸 | |
RU2640192C1 (ru) | Тест-система ИФА для серологической диагностики нодулярного дерматита крупного рогатого скота - Dermatitis nodularis bovum | |
RU2625031C1 (ru) | Иммуноферментная тест-система для серологической диагностики анаэробной энтеротоксемии животных и контроля напряженности поствакцинального иммунитета | |
CN111830263A (zh) | 一种绵羊肺炎支原体间接血凝检测方法的建立方法 | |
RU2810589C1 (ru) | Способ постановки реакции иммунофлюоресценции для диагностики лейкоза крупного рогатого скота | |
RU2429484C2 (ru) | Способ экспресс-диагностики ротавирусной инфекции в материалах из верхних дыхательных путей, иммуноглобулин флуоресцирующий сухой для его осуществления | |
RU2431675C1 (ru) | Способ получения антигенного препарата из mycobacterium tuberculosis с расширенным спектром серопозитивных фракций в реакции иммуноблотинга | |
KR100818779B1 (ko) | 질편모충 진단키트 | |
JP2004301537A (ja) | イヌジステンパーウイルス抗原の検出法 | |
CN109633183B (zh) | 一种溶酪大球菌间接血凝抗体检测试剂盒及其制备和应用 | |
JPH11279198A (ja) | Prdvに対する抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221014 Address after: Office No. 7, Block B, 6/F, Building 1+2, Tianhe New City Plaza, No. 38, Henan East Road, Xinshi District, Urumqi, 830000 Xinjiang Uygur Autonomous Region Patentee after: Xinjiang Wanfu Information Technology Co.,Ltd. Address before: No.137 Liyushan South Road, Xinshi District, Urumqi, Xinjiang Uygur Autonomous Region Patentee before: The First Affiliated Hospital of Xinjiang Medical University Patentee before: Zhongnong Huawei Biopharmaceutical (Hubei) Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Office No. 7, Block B, Floor 6, Building 1+2, Tianhe.New Town Plaza, No. 38, Henan East Road, UErvmqi, Xinjiang 830000 Patentee after: Xinjiang Yufu Biotechnology Co.,Ltd. Address before: Office No. 7, Block B, 6/F, Building 1+2, Tianhe New City Plaza, No. 38, Henan East Road, Xinshi District, Urumqi, 830000 Xinjiang Uygur Autonomous Region Patentee before: Xinjiang Wanfu Information Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210817 |